TP53 and hepatocellular carcinoma: Moreover, given that iron chelators such as desferrioxamine show an antitumor effect in patients with advanced HCC, it is crucial to investigate if iron chelation would result in the normalization of p53 expression in the liver of HH-mice and patients [79].